Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-07-28 00:00:00 ET · period of report 2025-07-24 · accession 0001127602-25-019632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-28 | 2025-07-24 | BCRX | Ghias Babar | CFO, Head of Corp Development | A - Grant | $0.00 | +147.0K | 147.0K | New | $0 |
| D | 2025-07-28 | 2025-07-24 | BCRX | Ghias Babar | CFO, Head of Corp Development | A - Grant | $0.00 | +305.0K | 305.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-24 | A | A | 147,000 | $0.00 | 147,000 | D | — | — | (F1) Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. |
| 2 | Derivative | Emp. Stock Option (Right to Buy) | 2025-07-24 | A | A | 305,000 | $0.00 | 305,000 | D | $8.55 · 2026-07-24 to 2035-07-24 | 305,000 Common Stock | (F2) Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. |